Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials

Autor: Merz, V. ^{∗, †, ∗}, Messina, C. ^‡, Zecchetto, C. ^{†, §}, Quinzii, A. ^{†, §}, Frisinghelli, M., Trentin, C., Salati, M. ^¶, Caffo, O., Melisi, D. ^{†, ||}

Publikováno v: In Clinical Oncology February 2024 36(2):87-97

Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma.

Autor: Merz V; Department of Medical Oncology, Santa Chiara Hospital, APSS, L.Go Medaglie d'Oro,9, 38122, Trento, Italy. valeria.merz@univr.it.; Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy. valeria.merz@univr.it., Maines F; Department of Medical Oncology, Santa Chiara Hospital, APSS, L.Go Medaglie d'Oro,9, 38122, Trento, Italy., Marcucci S; Department of General Surgery and HPB Unit, Santa Chiara Hospital, APSS, Trento, Italy., Sartori C; Department of Laboratory Medicine - Pathology Unit, Santa Chiara Hospital, APSS, Trento, Italy., Frisinghelli M; Department of Medical Oncology, Santa Chiara Hospital, APSS, L.Go Medaglie d'Oro,9, 38122, Trento, Italy., Trentin C; Department of Medical Oncology, Santa Chiara Hospital, APSS, L.Go Medaglie d'Oro,9, 38122, Trento, Italy., Kadrija D; Department of Medical Oncology, Santa Chiara Hospital, APSS, L.Go Medaglie d'Oro,9, 38122, Trento, Italy., Carbone FG; Department of Laboratory Medicine - Pathology Unit, Santa Chiara Hospital, APSS, Trento, Italy., Michielan A; Gastroenterology and Digestive Endoscopy Unit, Santa Chiara Hospital, APSS, Trento, Italy., Gabbrielli A; Gastroenterology and Digestive Endoscopy Unit, Santa Chiara Hospital, APSS, Trento, Italy.; Center for Medical Sciences (CISMed), University of Trento, Trento, Italy., Melisi D; Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy., Barbareschi M; Department of Laboratory Medicine - Pathology Unit, Santa Chiara Hospital, APSS, Trento, Italy.; Center for Medical Sciences (CISMed), University of Trento, Trento, Italy., Brolese A; Department of General Surgery and HPB Unit, Santa Chiara Hospital, APSS, Trento, Italy., Caffo O; Department of Medical Oncology, Santa Chiara Hospital, APSS, L.Go Medaglie d'Oro,9, 38122, Trento, Italy.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jul 11; Vol. 150 (7), pp. 347. Date of Electronic Publication: 2024 Jul 11.

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.

Autor: Rubatto M; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy. Electronic address: rubattomarco@gmail.it., Fava P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy., Stanganelli I; Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy., Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy., Pigozzo J; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Ridolfi L; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Tronconi MC; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Milan, Italy., Trojaniello C; Department of Melanoma and Cancer Immunotherapy, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Bersanelli M; Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy., Garutti M; CRO Aviano National Cancer Institute IRCCS, 33081 Aviano, Italy., Indini A; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., De Risi I; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., De Tursi M; Department of Medical, Oral and Biotechnological Sciences, Gabriele d'Annunzio University of Chieti and Pescara, Chieti, Italy., Merelli B; Unit of Medical Oncology, Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Piazza OMS 1, 24100 Bergamo, Italy., Morgese F; Clinica Oncologica, Università Politecnica delle Marche, AOU Ospedali Riuniti Di Ancona, Ancona, Italy., Occelli M; Department of Medicine, Clinical Oncology and Translational Research, Azienda Ospedaliera Santa Croce and Carle University Teaching Hospital, Cuneo, Italy., Cappellini GCA; UOC Oncologia Interpresidio, Ospedale Sandro Pertini, ASL Roma 2, Roma, Italy., Poletto S; Istituto di Candiolo, FPO - IRCCS, Candiolo, Italy; Department of Oncology, University of Turin, Torino, Italy., Fedele D; Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, Italy., Brugnara S; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Frisinghelli M; Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy., Formisano L; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy., Conca R; Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero, Vulture, Italy., Tucci M; Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', Section of Internal Medicine and Oncology, P.za Giulio Cesare, 11, 70124 Bari, Italy., Russillo M; Department of Cancer Medicine, Istituto Regina Elena, Rome, Italy., Ceroni L; University of Turin, Turin, Italy., Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy., Targato G; Department of Medical Oncology, Academic Hospital of Udine, Italy., Strippoli S; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy., Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Torino, Italy.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jul; Vol. 187, pp. 25-35. Date of Electronic Publication: 2023 Mar 23.

575P Impact of immunological alterations and post-operative biomarkers on long-term outcomes in patients with locally advanced rectal cancer: Results from the STAR-01 study cohort

Autor: Negri, F., Gnetti, L., Bottarelli, L., Campanini, N., Negru, M.E., Tamberi, S., Bergamo, F., Frisinghelli, M., Masi, G., Chiaulon, G., Tagliagambe, A., Siena, S., Petric, M., Morabito, A., Frassineti, G.L., Corsi, D.C., Rimassa, L., G.L. de'Angelis, Boni, L., Aschele, C.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S422-S422

OC.04.2: EFFECT OF PREOPERATIVE CHEMO-RADIATION ON TUMORINFILTRATING LYMPHOCYTES IN LOCALLY ADVANCED RECTAL CANCER AND TUMOR RESPONSE: RESULTS FROM THE STAR-01 COHORT.

Autor: Negri, F., Gnetti, L., Campanini, N., Azzoni, C., Bottarelli, L., Negru, E., Bergamo, F., Frisinghelli, M., Chiaulon, G., Tamberi, S., Masi, G., Petric, M., Tagliagambe, A., Morabito, A., Siena, S., Corsi, D., Rimassa, L., Frassineti, G.L., De'Angelis, G.L., Laghi, L.

Publikováno v: Digestive & Liver Disease; 2024 Supplement 2, Vol. 56, pS141-S142, 2p